Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
TFG - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
MS4A2 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
SCRN3 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
SCYL3 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
GTF2E1 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
P3H4 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
C8orf17 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
GEO DataSets Gene Profile neighbors
EDNRA - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
VRK1 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
MRPL52 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
HYPM - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
MERTK - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
PGM3 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
ALAS2 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
GRAP2 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
SPARC - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
VAMP4 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
R3HDM1 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
EIF5 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
PSMC3IP - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on